Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 5,318,000 | 5,255,000 | 5,280,000 | 5,418,000 | 5,266,000 |
| Cost of Goods | 2,105,000 | 2,228,000 | 2,135,000 | 2,319,000 | 2,122,000 |
| Gross Profit | 3,213,000 | 3,027,000 | 3,145,000 | 3,099,000 | 3,144,000 |
| Operating Expenses | 2,001,000 | 2,135,000 | 2,137,000 | 1,902,000 | 2,045,000 |
| Operating Income | 1,212,000 | 892,000 | 1,008,000 | 1,197,000 | 1,099,000 |
| Interest Expense | 126,000 | 79,000 | 78,000 | 59,000 | 89,000 |
| Other Income | 36,000 | 16,000 | 26,000 | -329,000 | 33,000 |
| Pre-tax Income | 1,122,000 | 829,000 | 956,000 | 809,000 | 1,043,000 |
| Income Tax | 225,000 | 174,000 | 218,000 | 140,000 | 231,000 |
| Net Income Continuous | 898,000 | 655,000 | 738,000 | 668,000 | 812,000 |
| Minority Interests | 4,000 | -3,000 | -3,000 | -3,000 | -3,000 |
| Net Income | $902,000 | $652,000 | $735,000 | $667,000 | $809,000 |
| EPS Basic Total Ops | 2.07 | 1.50 | 1.69 | 1.54 | 1.86 |
| EPS Basic Continuous Ops | 2.07 | 1.50 | 1.69 | 1.54 | 1.86 |
| EPS Diluted Total Ops | 2.07 | 1.50 | 1.69 | 1.54 | 1.86 |
| EPS Diluted Continuous Ops | 2.07 | 1.50 | 1.69 | 1.54 | 1.86 |
| EBITDA(a) | $1,706,000 | $1,365,000 | $1,507,000 | $1,419,000 | $1,581,000 |